SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-157222
Filing Date
2014-04-24
Accepted
2014-04-24 16:33:34
Documents
7
Period of Report
2014-04-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d713557d8k.htm 8-K 18672
2 EX-1.1 d713557dex11.htm EX-1.1 195271
3 EX-5.1 d713557dex51.htm EX-5.1 7228
4 EX-99.1 d713557dex991.htm EX-99.1 6851
5 EX-99.2 d713557dex992.htm EX-99.2 7310
6 GRAPHIC g713557ropes_graylogo.jpg GRAPHIC 7193
7 GRAPHIC g713557sarepta_logo.jpg GRAPHIC 10964
  Complete submission text file 0001193125-14-157222.txt   262120
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 857-242-3700
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 14782089
SIC: 2834 Pharmaceutical Preparations